HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J Verweij Selected Research

laniquidar (R101933)

5/2002Disposition of docetaxel in the presence of P-glycoprotein inhibition by intravenous administration of R101933.
7/2000Role of intestinal P-glycoprotein in the plasma and fecal disposition of docetaxel in humans.
4/2000The orally administered P-glycoprotein inhibitor R101933 does not alter the plasma pharmacokinetics of docetaxel.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J Verweij Research Topics

Disease

73Neoplasms (Cancer)
03/2019 - 01/2000
24Sarcoma (Soft Tissue Sarcoma)
11/2015 - 01/2000
10Fatigue
10/2010 - 01/2000
10Nausea
09/2010 - 05/2000
10Neutropenia
08/2008 - 03/2000
9Vomiting
09/2010 - 05/2000
9Breast Neoplasms (Breast Cancer)
01/2009 - 04/2000
8Diarrhea
01/2007 - 01/2000
7Ovarian Neoplasms (Ovarian Cancer)
09/2013 - 08/2001
5Exanthema (Rash)
09/2011 - 10/2001
5Thrombocytopenia (Thrombopenia)
06/2004 - 02/2001
4Colorectal Neoplasms (Colorectal Cancer)
01/2009 - 03/2000
4Fever (Fevers)
01/2005 - 01/2000
4Head and Neck Neoplasms (Head and Neck Cancer)
01/2005 - 01/2000
3Leiomyosarcoma
09/2013 - 05/2001
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2011 - 07/2000
3Alopecia (Baldness)
10/2010 - 05/2001
2Disease Progression
10/2012 - 01/2009
2Melanoma (Melanoma, Malignant)
06/2011 - 01/2000
2Hypersensitivity (Allergy)
10/2010 - 09/2001
2Anorexia
09/2010 - 02/2001
2Renal Cell Carcinoma (Grawitz Tumor)
05/2009 - 01/2009
2Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2009 - 01/2000
2Stomach Neoplasms (Stomach Cancer)
01/2009 - 01/2000
2Cardiotoxicity
02/2008 - 01/2000
2Sleepiness
01/2005 - 05/2002
2Hand-Foot Syndrome
01/2001 - 03/2000
1Hypertension (High Blood Pressure)
11/2015
1Ovarian Epithelial Carcinoma
10/2014
1Smooth Muscle Tumor
03/2014
1Chromosomal Instability (Chromosome Stability)
02/2010
1Aneuploidy (Aneuploid)
02/2010
1Constipation
07/2009
1Adenocarcinoma
01/2009
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2009
1Hepatocellular Carcinoma (Hepatoma)
01/2009
1Squamous Cell Carcinoma of Head and Neck
01/2009

Drug/Important Bio-Agent (IBA)

17Cisplatin (Platino)FDA LinkGeneric
09/2013 - 01/2000
15Paclitaxel (Taxol)FDA LinkGeneric
10/2014 - 06/2000
13Docetaxel (Taxotere)FDA Link
02/2015 - 04/2000
10Irinotecan (Camptosar)FDA LinkGeneric
01/2009 - 01/2000
8Pharmaceutical PreparationsIBA
03/2019 - 03/2000
8Imatinib Mesylate (Gleevec)FDA Link
06/2011 - 10/2001
7Doxorubicin (Adriamycin)FDA LinkGeneric
12/2014 - 01/2000
7PlatinumIBA
10/2014 - 01/2002
7IfosfamideFDA LinkGeneric
06/2010 - 01/2000
6Cytotoxins (Cytolysins)IBA
09/2012 - 02/2000
6Topotecan (Hycamtin)FDA LinkGeneric
07/2003 - 04/2000
4Capecitabine (Xeloda)FDA Link
01/2009 - 03/2000
4AnthracyclinesIBA
01/2009 - 01/2001
4Fluorouracil (Carac)FDA LinkGeneric
01/2009 - 01/2001
4Etoposide (VP 16)FDA LinkGeneric
04/2003 - 09/2001
3pazopanibFDA Link
11/2015 - 03/2014
3TrabectedinIBA
02/2013 - 01/2005
3Tyrosine Kinase InhibitorsIBA
02/2008 - 10/2003
3Transaminases (Aminotransferases)IBA
01/2005 - 03/2001
3thiamine triphosphorate (TTP)IBA
09/2003 - 03/2000
3GemcitabineFDA Link
07/2002 - 03/2001
3laniquidar (R101933)IBA
05/2002 - 04/2000
3EnzymesIBA
02/2001 - 10/2000
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2015 - 07/2001
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
11/2015 - 02/2014
2Carboplatin (JM8)FDA LinkGeneric
10/2014 - 11/2005
2MicroRNAs (MicroRNA)IBA
09/2013 - 09/2013
2Sunitinib (Sutent)FDA Link
06/2011 - 06/2010
2taxaneIBA
01/2009 - 03/2001
2Leucovorin (Folinic Acid)FDA Link
01/2009 - 03/2000
2CreatinineIBA
08/2008 - 02/2001
2Hormones (Hormone)IBA
11/2007 - 02/2004
2Antineoplastic Agents (Antineoplastics)IBA
10/2007 - 09/2007
2cremophor ELIBA
10/2001 - 06/2000
2Matrix Metalloproteinases (MMPs)IBA
07/2001 - 01/2001
2TransferasesIBA
02/2001 - 10/2000
24-amidinoindan-1-one 2'-amidinohydrazone (CGP 48664)IBA
05/2000 - 03/2000
1Biomarkers (Surrogate Marker)IBA
11/2015
1Hemoglobins (Hemoglobin)IBA
03/2014
1Erlotinib Hydrochloride (CP 358,774)FDA Link
09/2011
1Rosuvastatin Calcium (Crestor)FDA Link
06/2011
1JNJ-26483327IBA
09/2010
1DNA (Deoxyribonucleic Acid)IBA
02/2010
1Caspase 3 (Caspase-3)IBA
07/2009
1NF-kappa B (NF-kB)IBA
07/2009
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
05/2009
1MTOR InhibitorsIBA
05/2009
1TOR Serine-Threonine KinasesIBA
05/2009
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
05/2009
1BoronIBA
01/2009
1ixabepilone (BMS 247550)FDA Link
01/2009
1Sorafenib (BAY 43-9006)FDA Link
01/2009
1S-1 plus cisplatinIBA
01/2009
1Rituximab (Mabthera)FDA Link
01/2009
1Cetuximab (Erbitux)FDA Link
01/2009

Therapy/Procedure

20Therapeutics
10/2014 - 05/2000
20Drug Therapy (Chemotherapy)
02/2014 - 01/2000
4Combination Drug Therapy (Combination Chemotherapy)
11/2005 - 01/2001
3Radiotherapy
11/2008 - 08/2000
2Adjuvant Chemotherapy
12/2014 - 06/2001
2Duration of Therapy
11/2012 - 01/2000
2Intravenous Infusions
10/2001 - 01/2000
1Salvage Therapy
02/2013